Literature DB >> 11836283

Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.

Robert I McLachlan1, Liza O'Donnell, Peter G Stanton, Georgia Balourdos, Mark Frydenberg, David M de Kretser, David M Robertson.   

Abstract

Testosterone (T) treatment suppresses gonadotropin levels and sperm counts in normal men, but the addition of a progestin may improve the efficacy of hormonal contraception. This study aimed to investigate the speed and extent of suppression of testicular germ cell number induced by T plus or minus progestin treatment and correlate these changes with serum gonadotropins and inhibin B levels, testicular androgens, and sperm output. Thirty normal fertile men (31-46 yr) received either testosterone enanthate (TE, 200 mg im weekly) alone or TE plus depot medroxyprogesterone acetate (DMPA, 300 mg im once) for 2, 6, or 12 wk (n = 5 per group) before vasectomy and testis biopsy. Five men (controls) proceeded directly to surgery. The inclusion of DMPA led to a more rapid fall in serum FSH/LH levels (time to 10% baseline: FSH; 12.6 +/- 2.6 vs. 7.9 +/- 1.4 d; LH, 9.9 +/- 3.4 vs. 3.4 +/- 1.7 d, TE vs. TE+DMPA, respectively, mean +/- SD, both P < 0.0001), yet the mean time to reach a sperm count 10% of baseline was not different (23.7 +/- 7.3 vs. 25.3 +/- 13.9 d, NS). The maximum extent of FSH/LH suppression was identical at 12 wk (mean serum FSH 1.2 and 1.6%, and mean LH 0.3 and 0.2% of baseline: TE vs. TE+ DMPA, respectively) as was sperm count suppression (5 of 5 and 4 of 5 men, respectively, with sperm counts < or =0.1 x 10(6)/ml). Serum inhibin decreased to 55% control at 12 wk in the TE+DMPA group (P < 0.05) but was unchanged by TE treatment (86% control, NS). Testicular T levels declined to approximately 2% of control levels, but testicular dihydrotestosterone and 5alpha-androstane-3alpha,17beta-diol (Adiol) levels were not different to control. Germ cell numbers as determined by stereological methods did not differ between TE and TE+DMPA except at 2 wk when type B spermatogonia and early spermatocytes were significantly lower in the TE+DMPA group (P < 0.05). In all groups, a marked inhibition of Apale-->B spermatogonial maturation was seen along with a striking inhibition of spermiation. We conclude that: 1) the addition of DMPA hastens the onset of FSH/LH suppression, correlating with a more rapid impairment of spermatogonial development, but in the longer term, neither germ cell number nor sperm count differed; 2) testicular dihydrotestosterone and Adiol levels are maintained during FSH/LH suppression despite markedly reduced T levels suggesting up-regulation of testicular 5alpha-reductase activity; and 3) spermatogonial inhibition is a consistent feature, but spermiation inhibition is also striking and is an important determinant of sperm output.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836283     DOI: 10.1210/jcem.87.2.8231

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Experimentally induced androgen depletion accentuates ethnicity-related contrasts in luteinizing hormone secretion in asian and caucasian men.

Authors:  Johannes D Veldhuis; Anthony Bae; Ronald S Swerdloff; Ali Iranmanesh; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

2.  The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.

Authors:  M Y Roth; S T Page; K Lin; B D Anawalt; A M Matsumoto; B Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

3.  Spermiation: The process of sperm release.

Authors:  Liza O'Donnell; Peter K Nicholls; Moira K O'Bryan; Robert I McLachlan; Peter G Stanton
Journal:  Spermatogenesis       Date:  2011-01

4.  Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Authors:  M Y Roth; S T Page; K Lin; B D Anawalt; A M Matsumoto; C N Snyder; B T Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

5.  Exploring older adolescents' and young adults' attitudes regarding male hormonal contraception: applications for clinical practice.

Authors:  Arik V Marcell; Keith Plowden; Shameeka M Bowman
Journal:  Hum Reprod       Date:  2005-07-08       Impact factor: 6.918

6.  Serum LH correlates highly with intratesticular steroid levels in normal men.

Authors:  Mara Y Roth; K Lin; J K Amory; A M Matsumoto; B D Anawalt; C N Snyder; T F Kalhorn; W J Bremner; S T Page
Journal:  J Androl       Date:  2009-09-24

7.  Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Authors:  Mara Y Roth; Kat Lin; Katrine Bay; John K Amory; Bradley D Anawalt; Alvin M Matsumoto; Brett T Marck; William J Bremner; Stephanie T Page
Journal:  Fertil Steril       Date:  2012-10-03       Impact factor: 7.329

8.  Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

Authors:  M Y Roth; J J S Nya-Ngatchou; K Lin; S T Page; B D Anawalt; A M Matsumoto; B T Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2013-01-24       Impact factor: 5.958

9.  Effect of in vivo chronic exposure to clotrimazole on zebrafish testis function.

Authors:  Damien Baudiffier; Nathalie Hinfray; Catherine Ravaud; Nicolas Creusot; Edith Chadili; Jean-Marc Porcher; Rüdiger W Schulz; François Brion
Journal:  Environ Sci Pollut Res Int       Date:  2013-01-23       Impact factor: 4.223

10.  Effects of benzo(a)pyrene on intra-testicular function in F-344 rats.

Authors:  Anthony E Archibong; Aramandla Ramesh; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Donald D Lunstra
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.